Your browser does not support JavaScript!



[2018/09/28] NYMU Obtains Outstanding Results in the Areas of Industrial and Educational Development Research at the 2018 BioTaiwan Exhibition

2018 BioTaiwan Exhibition, where National Yang Ming University created the biggest theme pavilion of the past few years


BioTaiwan is the biggest biotechnology exhibition in the Asian Pacific area; nevertheless, this year there has been a breakthrough in scale. This year, National Yang Ming University also created the biggest theme pavilion of the past few years, exhibiting the various products of manufacturers who are linked to the Innovation and Incubator Center of NYMU. The pavilion also included innovative medical equipment from YM's Biomedical Engineering Research and Development Center, new ideas linked to the industry-education alliance, outlines of IP registered from the intellectual property service platform, and many other novel items. NYMU was also invited to participate in the first ever “Academia Technology Transfer Zone,” where they were able to present many of our professors’ latest research and development ideas in the area of biotechnology, as well as outlining in detail NYMU’s industry-university cooperation program and the university's various research and development results.


“2018 BioTaiwan Exhibition” was held in the Taipei Nangang Exhibition Hall and lasted from July 19 to July 22. It attracted participation by more than 600 Chinese, Japanese, Korean, Australian, German, Swiss, American and Canadian biotech companies, which eventually added up to 1,400 booths. NYMU was involved in cultivating the interest of manufacturers; these links help to maintain close industry-university relations and results in new biotech research and development ideas. Such products of industry-university relationships include the Bio-well medical beauty product “Evoquer,” the iWEECARE medical grade body temperature patch “Temp Pal™,” the Leon Biotech’s comprehensive service for health food certification and the Bened Biomed’s PS128 psychobiotic bacteria strain, which is patented in 17 countries. Not only have the results presented at 2018 BioTaiwan Exhibition stunned the Taiwanese biotechnology industry and medical personnel, but they have also increased the emergence of new biotechnology opportunities.



 " Bened Biomed won three prizes in 2017 (left); Associate Professor How-foo Chen from the Biophotonics Institute was

instrumental in developing a portable surface plasma resonance biomedical detector (Right)


In particular, NYMU Biomedical Center presented two innovative pieces of medical equipment at the exhibition. Associate Professor How-foo Chen from the Biophotonics Institute was instrumental in developing a portable surface plasma resonance biomedical detector. The unit is highly sensitive, portable and is able to quantitatively measure bacterial resistance to drugs or the presence of myocardial infarction, thus achieving its main purpose, which is to aid doctors during clinical examinations and to provide precautionary information about illnesses. The equipment is now being tested across various medical centers. Professor Fu-Jen Kao from the Biophotonics Institute was involved in developing a “optical fiber coupled laser illumination endoscope system”. This is a breakthrough in medical imaging that uses as its background research into photoelectrics. The instrument is able to decrease the risk of wound infection while at the same time being able to reduce the recovery time needed by the patient. The endoscope system also increases quality of the images obtained by the endoscope, thus assisting doctors with their diagnosis and when they are making medical judgments.


For the first time ever, the “Taiwan Academia Technology Transfer Zone” was used to exhibit the latest

in technology research and development technology


The “Academia Technology Transfer Zone” exhibited the work of three professors who were involved in the development of innovative technologies related to medical equipment. This platform was established with the hopes of providing greater exposure for these types of results and thus increasing cooperation opportunities.


Among these innovators, Professor Wen-Chuan Kuo’s research team working at the Biophotonics Institute has developed a “non-invasive, non-contact and high-resolution live optical sectioning technology without the need for calibration or the use of a contrast agent”. This can be applied to a number of different clinical fields including ophthalmology, diseases affecting the skin and diseases affecting the digestive tract. This technology was the result of a successful cooperation between industry and university. It is the first OCT biometry system to be developed, produced and manufactured in Taiwan. It is also the first multi-functional model on the market that combines corneal mapping, dry eye measurement and full-eye distance measurement. The full results will be published by the International Ophthalmology Society this year. The second exhibited technology was the result of the YM SPARK grant program. This technology provides oral structure and multi-contrast microvascular optical sectioning that helps greatly with the early screening for oral cancer. The technology has obtained an invention patent from the Republic of China, and the patent is also currently examined in China and by the World Intellectual Property Organization's Patent Cooperation Treaty system.



  From the left: the posters of the teams of Professor Wen-Chuan Kuo, Professor Huihau-Kenny Chiang,

and Professor Feng-Yi Yang


Secondly, Professor Huihau-Kenny Chiang's team working at the Department of Biomedical Engineering has noted the high prevalence and recurrence rate of urinary calculi throughout the world, which is linked to the fact that there is a tendency towards misinterpretation of the presence of crystals in urine using the technology available at present and human error. Therefore, the team developed an automated "Raman-based micro-fluidic channel urine crystallization measurement system". Using nano-iron oxide, the urine crystals are recovered and injected into a microfluidic channel, which allows the easy measurement of them via their Raman signal. This technology is able to increase diagnostic accuracy, as well as reducing the time needed for measurement; the result will be better diagnosis of crystals and calculi in urine by hospitals in the future.


Finally, Professor Feng-Yi Yang’s Medical Radiation research team working at the Department of Biomedical Imaging and Radiological Sciences exhibited a world leading “Transcranial Ultrasound Stimulation” system that uses low-intensity ultrasound to treat dementia. Compared with previously used medical treatments or invasive treatments, this technology has numerous advantages. This is a high level of safety, few side effects, non-invasiveness, etc. It is able to be used for low-intensity pulsed ultrasound irradiation of local brain regions or even the whole brain. This is done with high precision and allows deeper energy penetration into the brain. In addition to being used to treat degenerative brain diseases, it can also be helpful when treating patients with brain trauma, stroke, depression and psychosis. This technology has received a patent from the Republic of China and the US and Patent Cooperation Treaty patents are pending.